Herbs could be the cure to ovarian cancer!When it comes to treating this disorder, existing drugs are often limited in ...

CBD and THC kill ovarian cancer cells at doses that largely spare normal cells, disrupting survival pathways through multiple ...

Interrupting one function of a protein that plays a key role in cell signaling could enable the development of new cancer ...

CBD and THC—show surprisingly strong effects against ovarian cancer cells. Used together, they slow cell growth, reduce ...

Combining elacestrant with targeted agents produced “clinically meaningful” outcomes for patients with locally advanced or metastatic ER-positive/HER2-negative breast cancer who have received at least ...

A large, multi-institution study led by a Brown University physician-scientist could have important implications for the ...

Trastuzumab deruxtecan (T-DXd; Enhertu), is a HER2-targeting ADC that is used in ET-treated HER2-low or HER2-ultralow disease and offered meaningful results in DESTINY-Breast04. In a 2025 real-world ...

The researchers also examined how the compounds affected cell signalling pathways. They found evidence that CBD and THC ...

The first-line standard of care for HR-positive/HER2-negative breast cancer is cyclin-dependent kinase (CDK)4/6 inhibitors combined with endocrine therapy (ET). This dual-therapy targets a pathway ...

Although our study is still preliminary, it lays an important foundation for future research into the potential applications ...

PROVIDENCE, R.I. [Brown University] - Interrupting one function of a protein that plays a key role in cell signaling could ...

Rakovina Therapeutics Inc ( ($TSE:RKV) ) has provided an update. Rakovina Therapeutics announced that its senior executives will participate in ...